Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.

Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A; Academic Alliance for AIDS Care and Prevention in Africa.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):187-93.

PMID:
17693883
2.
3.

Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens.

Renaud-Théry F, Nguimfack BD, Vitoria M, Lee E, Graaff P, Samb B, Perriëns J.

AIDS. 2007 Jul;21 Suppl 4:S89-95.

PMID:
17620758
4.

High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.

van Griensven J, De Naeyer L, Mushi T, Ubarijoro S, Gashumba D, Gazille C, Zachariah R.

Trans R Soc Trop Med Hyg. 2007 Aug;101(8):793-8. Epub 2007 Apr 30.

PMID:
17467756
5.

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.

Hill A, Ruxrungtham K, Hanvanich M, Katlama C, Wolf E, Soriano V, Milinkovic A, Gatell J, Ribera E.

Expert Opin Pharmacother. 2007 Apr;8(5):679-88. Review.

PMID:
17376022
6.

Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.

Forna F, Liechty CA, Solberg P, Asiimwe F, Were W, Mermin J, Behumbiize P, Tong T, Brooks JT, Weidle PJ.

J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):456-62.

PMID:
17279048
7.
8.
9.

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JM; 2NN Study team.

Lancet. 2004 Apr 17;363(9417):1253-63.

PMID:
15094269
10.

Dose-related activity of stavudine in patients infected with human immunodeficiency virus.

Petersen EA, Ramírez-Ronda CH, Hardy WD, Schwartz R, Sacks HS, Follansbee S, Peterson DM, Cross A, Anderson RE, Dunkle LM.

J Infect Dis. 1995 Mar;171 Suppl 2:S131-9.

PMID:
7861018
11.

Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.

Murray HW, Squires KE, Weiss W, Sledz S, Sacks HS, Hassett J, Cross A, Anderson RE, Dunkle LM.

J Infect Dis. 1995 Mar;171 Suppl 2:S123-30.

PMID:
7861017
12.

Design and implementation of the stavudine parallel-track program.

Anderson RE, Dunkle LM, Smaldone L, Adler M, Wirtz C, Kriesel D, Cross A, Martin RR.

J Infect Dis. 1995 Mar;171 Suppl 2:S118-22.

PMID:
7861016

Supplemental Content

Support Center